BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250313T190000
DTEND;TZID=Africa/Nairobi:20250313T203000
DTSTAMP:20260424T035851
CREATED:20250611T192853Z
LAST-MODIFIED:20250622T142307Z
UID:38882-1741892400-1741897800@kesho-kenya.org
SUMMARY:Women in Oncology
DESCRIPTION:International Women’s Day: Women in Oncology \nModerator: Ms Benda Kithaka \nSpeakers & Topics: \n\nDr Catherine Nyongesa: Women in Leadership\nDr Khadija Warfa: Challenges Faced by Women in Oncology\nDr Gladwell Kiarie: Women in Oncology – How to Step Up the Game!\nProf Nazik Hammad: Harnessing Solidarity Between African Women in Oncology\n\nDr. Warfa discussed the multifaceted challenges faced by female oncologists in Africa\, including work-life imbalance\, gender-based microaggressions\, and structural sexism. She emphasized how family responsibilities\, limited mentorship\, and hierarchical work environments hinder progress. Solutions include flexible work arrangements\, inclusive leadership\, bias training\, and equitable opportunities for advancement. She also highlighted the importance of accurate gender representation in medical discourse and the superior clinical outcomes observed among female physicians. \nDr. Nyongesa focused on leadership development for women in oncology\, identifying critical attributes such as emotional intelligence\, vision\, resilience\, and effective communication. She encouraged mentorship\, strategic positioning\, and self-awareness. The presentation promoted intentional leadership development and emphasized that empowered women are key to empowering entire communities. \nDr. Kiarie highlighted systemic gender disparities in oncology\, such as underrepresentation in leadership\, editorial boards\, and conferences. She emphasized key challenges including lack of mentorship\, pay gaps\, burnout\, and societal biases. Proposed solutions included implementing mentorship and sponsorship programs\, advocating for inclusive policies\, prioritizing self-care\, and establishing supportive networks. She stressed the importance of visibility\, advocacy\, and proactive self-promotion for career progression
URL:https://kesho-kenya.org/event/women-in-oncology/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2025/06/Women-in-Oncology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250306T190000
DTEND;TZID=Africa/Nairobi:20250306T203000
DTSTAMP:20260424T035851
CREATED:20250611T193255Z
LAST-MODIFIED:20250622T142307Z
UID:38887-1741287600-1741293000@kesho-kenya.org
SUMMARY:Updates in Myeloma Management
DESCRIPTION:Moderator: Dr Angela Mcligieyo \nSpeakers & Topics: \n\nDr M. B. Agarwal: Front‑line Therapy Trends\nDr Rohini Radia: Transplant‑Eligible vs Ineligible Patients\nDr M. D. Maina: Evidence‑Based Maintenance\nDr Boniface Githae: Contemporary Relapse Strategies\n\nDr. Maina addressed Smoldering Multiple Myeloma (SMM)\, emphasizing risk stratification to predict progression to active myeloma. The 2/20/20 IMWG model (based on FLC ratio and bone marrow plasma cell %)\, and the Spanish model using immunoparesis and plasma cell phenotyping\, were presented. Patients with ≥2 risk factors have a 50% chance of progression within 2 years. Ongoing efforts to integrate clinical and genomic risk markers aim to guide early therapeutic interventions. \nDr. Radia emphasized that autologous stem cell transplant (ASCT) remains the standard of care for transplant-eligible patients after induction chemotherapy. Key findings from major trials (IFM2009\, EMN02/H095) showed that ASCT improves progression-free survival (PFS) but does not significantly impact overall survival (OS). Post-ASCT maintenance therapy with lenalidomide improves PFS across all cytogenetic risk groups. CAR-T cell therapy and bispecific antibodies like Teclistamab and Elranatamab show promise in relapsed/refractory multiple myeloma (RRMM)\, offering new options with high response rates\, albeit with logistical and toxicity concerns. Kenyan real-world data shows promising survival outcomes with ASCT. \nDr. Githaiga presented practical approaches to diagnosis\, transplant eligibility\, and treatment selection. Diagnostic workups include comprehensive labs and bone marrow studies. For transplant-eligible patients\, quadruplet regimens like Dara-VRd followed by ASCT and lenalidomide maintenance are preferred. In high-risk cases\, bortezomib-based maintenance is advised. In non-transplant candidates\, extended triplet regimens followed by maintenance were recommended. He also highlighted Kenyan drug cost considerations and the importance of supportive care with antivirals\, antibiotics\, and bone-targeting agents.
URL:https://kesho-kenya.org/event/updates-in-myeloma-management/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/Updates-in-Myeloma-Management-e1749726883405.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250305T190000
DTEND;TZID=Africa/Nairobi:20250305T203000
DTSTAMP:20260424T035851
CREATED:20251222T171137Z
LAST-MODIFIED:20251223T152927Z
UID:40763-1741201200-1741206600@kesho-kenya.org
SUMMARY:Kidney Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/kidney-cancer-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250227T190000
DTEND;TZID=Africa/Nairobi:20250227T203000
DTSTAMP:20260424T035851
CREATED:20250611T193814Z
LAST-MODIFIED:20250622T142307Z
UID:38891-1740682800-1740688200@kesho-kenya.org
SUMMARY:AML: A Local Perspective
DESCRIPTION:Moderator: Prof Abinya \nSpeakers & Topics: \n\nDr Anne Mwirigi: Local Experience at a Tertiary Hospital\nDr Rohini Radia: The Role of Cytogenetics & Molecular Markers\nDr Peter Oyiro: Genomic Classification & Medical Oncology Pathways\nDr Beatrice Jepngetich: Panelist Discussion\nDr Mercy Gatua: Panelist Discussion\n\n Summary \nAML is genetically heterogeneous\, with most patients having multiple driver mutations.\n– WHO 2022 classification emphasizes genetic abnormalities over morphology or blast count.\n– Defining cytogenetic lesions like inv(16) or t(8;21) now suffice for diagnosis even with <20% blasts. \nDiagnostic Work-Up \n– FBC and peripheral blood smear\n– Bone marrow aspirate: morphology\, flow cytometry\, LAIP for MRD\n– Cytogenetics: Karyotyping and FISH\n– Next-Generation Sequencing (NGS): TP53\, NPM1\, etc.\n– Bone marrow trephine with immunocytochemistry. \nClinical Implications \n– Risk stratification through cytogenetics + molecular testing informs prognosis and treatment plan.\n– Favorable-risk patients may receive chemotherapy; adverse-risk patients considered for early allogeneic transplant.\n– MRD monitoring increasingly guides transplant decisions. \nTakeaways \n– AML is curable in a subset with intensive chemo + risk-adapted approach.\n– Precision oncology depends on accessible molecular diagnostics.\n– LMICs face challenges integrating NGS-based stratification.\n– Hypomethylating agents + Venetoclax offer promise in select patient groups.
URL:https://kesho-kenya.org/event/aml-a-local-perspective/
LOCATION:Aga Khan University\, Nairobi
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/A-Local-Perspective-e1749671173338.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250220T190000
DTEND;TZID=Africa/Nairobi:20250220T193000
DTSTAMP:20260424T035851
CREATED:20250217T194237Z
LAST-MODIFIED:20250622T142307Z
UID:38895-1740078000-1740079800@kesho-kenya.org
SUMMARY:International Childhood Cancer Day
DESCRIPTION:Moderator: Dr Alice Gichemi \nSpeaker & Topic: \nDr Terry Vik: Flow Cytometry for Rapid Diagnosis of Lymphoid Malignancies in Children & Teenagers \nGlobal Context \n– Childhood cancer cure rates: 80% in high-income countries\, ~30% in LMICs.\n– Barriers: delayed diagnosis\, treatment abandonment\, limited diagnostic access.\n– WHO/SIOP target: Double survival and save 1 million children by 2030. \n Leukemia Diagnosis in Kenya \n– Common signs: Pallor\, Pyrexia\, Purpura\, Pain (bony).\n– First-line tests: CBC and peripheral smear.\n– Many children present with Hgb < 7.0 — indicates late presentation. \nRole of Flow Cytometry \n– Globally standard for classifying ALL/AML.\n– In Kenya\, it’s reducing time-to-treatment\, especially in Burkitt Lymphoma (from 13.6 to 10.5 days).\n– Used on both bone marrow and peripheral blood samples for early diagnosis. \n Clinical Pilot Highlights \n– MTRH pilot expanding to 100 patients in 2026.\n– Focus: Feasibility of flow cytometry in peripheral blood diagnostics.\n– Goal: Develop scalable and SHIF/NHIF-coverable diagnostic methods. \nKey Clinical Takeaways \n– Recognize early signs of leukemia using the 4 P’s.\n– Flow cytometry is feasible and impactful in Kenya.\n– Early diagnosis can save lives — integration into local protocols is critical.
URL:https://kesho-kenya.org/event/international-childhood-cancer-day/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/International-Childhood-Cancer-Day-e1749670857260.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250219T190000
DTEND;TZID=Africa/Nairobi:20250219T203000
DTSTAMP:20260424T035851
CREATED:20251222T170110Z
LAST-MODIFIED:20251223T152934Z
UID:40761-1739991600-1739997000@kesho-kenya.org
SUMMARY:Gallbladder & Bile Duct Cancer  Awareness
DESCRIPTION:
URL:https://kesho-kenya.org/event/gallbladder-bile-duct-cancer-awareness/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250206T190000
DTEND;TZID=Africa/Nairobi:20250206T203000
DTSTAMP:20260424T035851
CREATED:20250203T194848Z
LAST-MODIFIED:20250623T131746Z
UID:38898-1738868400-1738873800@kesho-kenya.org
SUMMARY:United for Cancer Prevention
DESCRIPTION:United for Cancer Prevention – People‑Centered Approaches in Healthcare\n\nModerator: Dr Douglas Nyandika\n\nSpeakers & Topics:\n\n 	Carol Wakesa: Community‑Led Prevention Strategies\n 	Dr Joan‑Paula Boit: Risk‑Reduction in Gynaecologic Cancers\n 	Dr Jerome Katamba: Behavioural Science & Cancer Prevention\n 	Dr Francis Makokha: The Socio‑Economic Determinants of Prevention Uptake\n 	Mr David Makumi: Building Survivor‑Led Advocacy Networks
URL:https://kesho-kenya.org/event/united-for-cancer-prevention/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/United-for-Cancer-Prevention-e1749671294368.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250205T190000
DTEND;TZID=Africa/Nairobi:20250205T203000
DTSTAMP:20260424T035851
CREATED:20251222T165950Z
LAST-MODIFIED:20251223T153047Z
UID:40757-1738782000-1738787400@kesho-kenya.org
SUMMARY:World Cancer Day   Building a Resilient Oncology  Workforce: Addressing Capacity  Gaps in Cancer Management in  Kenya
DESCRIPTION:
URL:https://kesho-kenya.org/event/world-cancer-day-building-a-resilient-oncology-workforce-addressing-capacity-gaps-in-cancer-management-in-kenya/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250123T190000
DTEND;TZID=Africa/Nairobi:20250123T203000
DTSTAMP:20260424T035851
CREATED:20250611T183601Z
LAST-MODIFIED:20250622T142307Z
UID:38855-1737658800-1737664200@kesho-kenya.org
SUMMARY:Cervical Cancer Care
DESCRIPTION:Advanced Ovarian Cancer \nModerator: Prof Rose J. Kosgei \nSpeakers & Topics: \n\nProf Omenge Orang’o: Management of Epithelial Ovarian Cancer\nDr Peter Oyiro: PARP Inhibitors in Ovarian Cancer\nDr Charles Muteshi: Fertility Preservation in Ovarian Cancer\n\nEpidemiology and Diagnosis (Prof. Omenge Oran’go) \n– Ovarian cancer remains a significant cause of cancer mortality among women due to its asymptomatic nature in early stages.\n– Kenya sees many cases diagnosed at advanced stages (III/IV)\, primarily due to non-specific symptoms and lack of screening.\n– Important to understand pelvic anatomy and tumor spread patterns for accurate diagnosis and surgical planning. \nFertility Preservation in Ovarian Cancer (Dr. Charles Muteshi) \n– Fertility-sparing surgery should be considered in selected early-stage epithelial ovarian cancers (Stage I).\n– Discussion on embryo/oocyte cryopreservation for patients undergoing gonadotoxic treatment.\n– Emphasized need for multidisciplinary counseling and prompt fertility consultations to ensure oncologic safety and reproductive potential. \nRole of PARP Inhibitors (Dr. Peter Oyiro) \n– PARP inhibitors like Olaparib offer significant benefits in BRCA-mutated and homologous recombination-deficient (HRD) ovarian cancers.\n– SOLO-1 and SOLO-2 studies demonstrated prolonged progression-free survival and delayed recurrence in both frontline and maintenance settings.\n– 7-year follow-up data show sustained benefit\, with over 48% progression-free survival in Olaparib arms.\n– Low incidence of serious adverse events\, with anemia\, fatigue\, and nausea as the most common.\n– Highlighted integration into Kenya Cancer Treatment Guidelines and importance of HRD testing.
URL:https://kesho-kenya.org/event/cervical-cancer-care/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/Cervical-Cancer-scaled-e1749667096838.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241031T193000
DTEND;TZID=Africa/Nairobi:20241031T203000
DTSTAMP:20260424T035851
CREATED:20241011T163557Z
LAST-MODIFIED:20250622T144124Z
UID:10032-1730403000-1730406600@kesho-kenya.org
SUMMARY:HER2 Breast Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/her2-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241024T193000
DTEND;TZID=Africa/Nairobi:20241024T203000
DTSTAMP:20260424T035851
CREATED:20241011T163444Z
LAST-MODIFIED:20250622T144124Z
UID:10030-1729798200-1729801800@kesho-kenya.org
SUMMARY:Tripple Negative Breast Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/tripple-negative-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241017T193000
DTEND;TZID=Africa/Nairobi:20241017T203000
DTSTAMP:20260424T035851
CREATED:20241011T163154Z
LAST-MODIFIED:20250622T144124Z
UID:10028-1729193400-1729197000@kesho-kenya.org
SUMMARY:Breast Cancer in Young Women
DESCRIPTION:
URL:https://kesho-kenya.org/event/breast-cancer-in-young-women/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241010T193000
DTEND;TZID=Africa/Nairobi:20241010T203000
DTSTAMP:20260424T035851
CREATED:20241011T162615Z
LAST-MODIFIED:20250622T144125Z
UID:10024-1728588600-1728592200@kesho-kenya.org
SUMMARY:Hormone Receptor
DESCRIPTION:
URL:https://kesho-kenya.org/event/hormone-receptor-copy/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241010T190000
DTEND;TZID=Africa/Nairobi:20241010T203000
DTSTAMP:20260424T035851
CREATED:20241011T162538Z
LAST-MODIFIED:20250622T144124Z
UID:10022-1728586800-1728592200@kesho-kenya.org
SUMMARY:Positive Breast Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/positive-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241003T073000
DTEND;TZID=Africa/Nairobi:20241003T203000
DTSTAMP:20260424T035851
CREATED:20241011T161126Z
LAST-MODIFIED:20250622T144125Z
UID:10020-1727940600-1727987400@kesho-kenya.org
SUMMARY:Cervical Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/cervical-cancer-2/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240926T193000
DTEND;TZID=Africa/Nairobi:20240926T203000
DTSTAMP:20260424T035851
CREATED:20240704T122734Z
LAST-MODIFIED:20250622T144126Z
UID:9877-1727379000-1727382600@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/prostate-cancer-7/
CATEGORIES:Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240926T193000
DTEND;TZID=Africa/Nairobi:20240926T203000
DTSTAMP:20260424T035851
CREATED:20240704T140045Z
LAST-MODIFIED:20250622T144125Z
UID:9888-1727379000-1727382600@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/prostate-cancer-8/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240919T193000
DTEND;TZID=Africa/Nairobi:20240919T203000
DTSTAMP:20260424T035851
CREATED:20240704T122542Z
LAST-MODIFIED:20250622T144126Z
UID:9875-1726774200-1726777800@kesho-kenya.org
SUMMARY:Word CML Day
DESCRIPTION:
URL:https://kesho-kenya.org/event/word-cml-day/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240912T193000
DTEND;TZID=Africa/Nairobi:20240912T203000
DTSTAMP:20260424T035851
CREATED:20240704T122332Z
LAST-MODIFIED:20250622T144126Z
UID:9872-1726169400-1726173000@kesho-kenya.org
SUMMARY:Endrometrial Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/endrometrial-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240905T193000
DTEND;TZID=Africa/Nairobi:20240905T203000
DTSTAMP:20260424T035851
CREATED:20240704T122050Z
LAST-MODIFIED:20250622T144126Z
UID:9870-1725564600-1725568200@kesho-kenya.org
SUMMARY:Childhood Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/childhood-cancer-3/
CATEGORIES:Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240829T190000
DTEND;TZID=Africa/Nairobi:20240829T203000
DTSTAMP:20260424T035851
CREATED:20240829T080756Z
LAST-MODIFIED:20250622T144125Z
UID:9931-1724958000-1724963400@kesho-kenya.org
SUMMARY:Management of Cervical Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Khadija Warfa\nKhadija Warfa is a Gynecologic Oncologist\, who completed her gynaecological oncology fellowship at the University of Calgary\, Canada. \nCurrently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital\, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students. \nDr. Warfa is a member of the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya. \nDr Sheynaz Bassa\nSheynaz Bassa is the Head of Radiation Oncology at Steve Biko Academic hospital\, University of Pretoria. Her research interest is on genitourinary cancers\, with a focus on HIV related cervix cancers. \nDr Jonathan Wawire\nJonathan Wawire is an anatomic pathologist and Assistant Professor at Aga Khan University Hospital\, Nairobi\, with a strong background in Gynecologic Pathology. \nHe has held various leadership roles within the Kenya Association of Clinical Pathologists\, contributing to the advancement of pathology education and practice in the region. \nDr. Wawire is also a dedicated researcher with numerous peer-reviewed publications\, and he has received the International Society of Gynecological Pathologists Young Member Award for his work on endometrial carcinoma in Kenya. His commitment to fostering collaboration through case reviews and conferences underscores his dedication to improving pathology services and training. \nDr Omar Abdihamid (Moderator)\nOmar Abdihamid is a Consultant Oncologist working in Nairobi and Garissa Cancer Center. He holds a master’s degree in Clinical Oncology from Central South University in China. \nHis main research and clinical interests include improving care in cancers of the head and neck\, Esophagus and Genitourinary cancers. \nDr. Omar is passionate about global oncology\, cancer care access\, and equity in low- and middle-income countries\, and advocates for culturally based cancer care\, affordability\, patient education\, digital health\, and access to treatment. \nHe is also a published cancer researcher\, editor\, and reviewer in medical journals.\nHe is a fellow of \n\n2023 American Society of Clinical Oncology (ASCO) International Development Education Award (IDEA)\nFellow of the African Cancer Leadership Institute (ACLI)\,\nThe winner of the ASCO VOICES 2022 Award– for highlighting the state of cancer care in Kenya.\n\n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”REGISTRATION” color=”danger” link=”url:https%3A%2F%2Fus02web.zoom.us%2Fwebinar%2Fregister%2FWN_Fqjdhrm_Qh2ooxOMHvDvyg”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/management-of-cervical-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/08/Management-of-Cervical-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240820T193000
DTEND;TZID=Africa/Nairobi:20240825T203000
DTSTAMP:20260424T035851
CREATED:20240704T123725Z
LAST-MODIFIED:20250622T144125Z
UID:9884-1724182200-1724617800@kesho-kenya.org
SUMMARY:Hepatobiliary Conference
DESCRIPTION:
URL:https://kesho-kenya.org/event/hepatobiliary-conference/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240815T190000
DTEND;TZID=Africa/Nairobi:20240815T203000
DTSTAMP:20260424T035851
CREATED:20240704T123012Z
LAST-MODIFIED:20250622T144125Z
UID:9881-1723748400-1723753800@kesho-kenya.org
SUMMARY:Nutrition for Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nMs Joyce Awuor\nB.A. (Sociology & Psychology)\, BSc. (Human Nutrition & Dietetics)\, Pg. (Pediatric Nutrition)\nJoyce Awuor Joyce is a Consultant Dietitian and has recently been awarded the prestigious AfriGlo Women’s Choice Award for The Nutritionist of the Year 2024. \nMs. Joyce previously worked at The Aga Khan University Hospital and Coptic Hospital and currently serves as a Consultant Dietitian at Waridi Children’s Medical Centre and Mirazi Healthcare. Additionally\, Ms. Joyce holds a lecturer position (Dep. of Human Nutrition & Dietetics) at the Kenya Medical Training College (KMTC) in Karen Campus. She is also the CEO and Founder of Diet Select\, an organization dedicated to providing expert dietary and nutritional guidance. Diet Select can be accessed across all social media platforms\, where Ms. Joyce and her team share videos and insights on various diet and nutrition topics. \nHer expertise has been widely recognized in various health segments in mainstream media\, where she has been featured in numerous health interviews and as a speaker at several scientific conferences\, where she contributes to advancing knowledge in the field of dietetics and nutrition. \nWith a strong passion for disseminating scientific information on healthy eating\, Ms. Joyce is committed to enhancing public awareness and promoting healthy food choices and practices for overall well-being. \nDr Gladwell Kiarie\nGladwell Kiarie graduated with MBChB (Bachelor of Medicine and Bachelor of Surgery) degrees from The University of Nairobi and went head to receive her post-graduate degree in Internal Medicine from the same institution. After receiving her undergraduate degrees\, she did her internship at the Kenyatta National Hospital before proceeding to pursue her fellowship in Medical Oncology in London\, England. \nAfter sub-specialization in Medical Oncology\, she returned to Kenya where she was one of the founding members of the Oncology Unit at the Aga Khan University Hospital and was also part of the team that set up the first Kenyatta National Hospital Tumor Board in 2007 that involved multiple personnel from surgical and medical departments. \nShe then joined the University of Nairobi in the Clinical Medicine Department as a Senior Lecturer. Soon afterwards\, she enrolled in a PhD program with the Bart’s Cancer Institute under the supervision of Professor John Gribben. She recently received Fellowship to the Royal College of Physicians of Edinburgh (FRCPE). \nDr Kiarie currently runs a private practice at The Nairobi Hospital and also reviews patients at other leading hospitals in Nairobi and Nakuru including The Aga Khan University Hospital\, MP Shah Hospital\, and Avenue Hospital. She also serves in the Kenya Medical Practitioners and Dentists Board since her appointment in 2015 to the Regulatory Department of the Board. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO) where she also served as the treasurer in 2004 and is also a full member of the American Society of Clinical Oncology (ASCO) as well as European Society for Medical Oncology (ESMO). \nShe continues to be an advocate for early diagnosis of cancer and is greatly involved in programs that focus on providing easy access to basic screening services to the under privileged including setting up oncology services at the county level. In recognition of this\, she won the Union for International Cancer Control (UICC) in 2014 for screening in poor settings. \nMr Josphat Nthae Nzusyo (Moderator)\nJosphat Nthae Nzusyo is a goal-oriented\, assertive\, and dedicated healthcare professional with a Bachelor of Science in Nursing from the University of Eastern Africa\, Baraton. He is a SIOP-trained Pediatric Oncology Nursing Trainer (2023 Tanzania Cohort)\, trained in Childhood palliative care by KEHPCA and a passionate advocate for childhood cancer patients. \nCurrently serving as a nurse team leader and researcher in the Pediatric Hematology Oncology unit at Kenyatta National Hospital\, He is on a mission to save lives and provide holistic care to young cancer warriors. He actively engages in improving pediatric oncology nursing care\, education\, and training. His dedication to continuous learning ensures he remains at the forefront of pediatric oncology\, consistently implementing best practices and innovative care strategies. \nJosphat’s leadership and commitment to excellence have led him to spearhead several quality improvement initiatives aimed at enhancing the quality of care for childhood cancer patients. His work not only focuses on clinical outcomes but also emphasizes the importance of compassionate\, patient-centered care. As a trained professional in childhood palliative care\, he integrates this crucial aspect into his practice\, ensuring comprehensive support for patients and their families throughout their cancer journey. \nIn addition to his clinical and research roles\, He is a respected trainer and mentor\, inspiring fellow healthcare professionals to excel in delivering exceptional care. His involvement in continuous education and training programs helps equip nurses with the skills and knowledge needed to tackle the challenges of pediatric oncology nursing hence improving the lives of childhood cancer patients.[/vc_column_text][vc_video link=”” title=”Webinar Recording”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/nutrition-for-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/Nutrition-and-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240808T190000
DTEND;TZID=Africa/Nairobi:20240808T203000
DTSTAMP:20260424T035851
CREATED:20240704T122842Z
LAST-MODIFIED:20250622T144126Z
UID:9879-1723143600-1723149000@kesho-kenya.org
SUMMARY:Sickle Cell Disease
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Miguel R. Abboud\nMiguel R. Abboud earned his medical degree and then pediatrics training at the American University of Beirut\, Lebanon (1984). He completed his hematology-oncology specialty training at the Memorial Sloan-Kettering Cancer Center and The New York Hospital\, Cornell University Medical Center\, New York\, NY\, USA (1987). He was professor at Medical University of South Carolina until in August 2002\, he became the first Medical Director of the Children’s Cancer Center of Lebanon (CCCL) at the American University of Beirut Medical Center in Lebanon and Professor of Pediatrics at AUB. He established highly visible and successful bone marrow transplant\, limb salvage surgery\, and sickle cell disease programs as well as an acute lymphoblastic leukemia research protocol in collaboration with the Leukemia/Lymphoma Division at St. Jude Children’s Research Hospital in Memphis\, TN\, USA. In February 2011\, he was appointed as Chairman of the Department of Pediatrics and Adolescent Medicine at AUBMC and was offered tenured appointment as Professor of Pediatrics at AUB in July 2018. He was assigned as Scientific Advisor of the SCD Association of America in May 2019. He is also the chair of the Red Cell Biology Scientific Committee of the American Society of Hematology. He is consultant on multiple Sickle Cell Disease multicenter clinical trials protocol development. He has published above 170 publications in peer-reviewed journals. \nDr Abboud has been accorded numerous awards and honors. These include Physician of the Year by the National Committee for Lebanese Children in 2007\, a “Miracle Maker” award from A.H. Robbins in 1995\, and the Mitchell Rubin Research Award in Pediatrics in 1993\, among others. \nDr Doreen Mutua\nDoreen Mutua is a pediatrician whose passion for children with blood disorders and cancer was ignited during her residency training at the University of Nairobi where she noticed that most of these children had dismal outcomes due to late presentation\, lack of appropriate diagnostic and treatment facilities. \nDr. Mutua is a beneficiary of a two year training program conducted as a twinning program between Jimma University (Ethiopia) and ASLAN Project (a USA based Non- Governmental organization) that seeks to build capacity of   low and middle income countries in treating children with blood disorders and cancer. \nShe completed her training in May 2018 and returned back to Kenya to establish hematology/oncology services that include centers of excellence for pediatric cancer care and comprehensive sickle cell care at the Gertrude’s Children’s Hospital. \nShe is passionate about raising awareness on childhood cancer with regard to early detection\, establishing treatment guidelines and improving outcomes of Kenyan children who have cancer. She is also keen on seeing the establishment of comprehensive sickle cell centers in the country which can help reduce the morbidity and mortality of these patients. \nDr Anne Mwirigi\nAnne Mwirigi is an Assistant Professor and Consultant Haematologist working at the Aga Khan University Hospital in Nairobi\, Kenya. She obtained her undergraduate MBChB from the University of Glasgow in 2002. After her house jobs and a medical rotation in Glasgow\, she moved to London in February 2007. \nHer career in Haematology began as a senior house officer at King’s College Hospital\, following which she was accepted on the Guy’s and St Thomas’ NHS Trust Specialist Registrar Rotation in 2009. She obtained her certificate of completion of training in 2014\, and thereafter took on consultant haematologist positions for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals. \nDr Mwirigi has a passion for haematology and always planned to practice haematology in her country of birth\, Kenya. Since moving back in December 2016\, she has engaged with haematopathologists and clinical haematologists in the region\, and is involved collaborative ventures aimed at improving the quality of haematology services in Kenya. She was a key member of the scientific committee which organised the Haematology and Oncology Society of Africa 3rdinaugural conference held in Nairobi in August 2017. \nDr Sarah Muma\nSarah Muma is a Pediatric Hemato – Oncologist at Kenyatta National Hospital. \nShe is a graduate of the University of Nairobi where she received her Bachelor’s degree (MBChB) as well as her Master’s degree in Pediatrics and Child Health. Dr Muma did a fellowship in Pediatric Oncology at Frere Hospital\, Walter Sisulu University in East London\, South Africa. She also holds a Master’s degree in Advanced Oncology from Ulm University in Germany. Her main interest is in developing low-cost\, high impact models of management for children with cancer in low-income settings. \nDr Rohini Radia\nRohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005. \nDuring her haematology training and work as a consultant\, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation\, including 10 years at consultant level at The Russell Centre for Clinical Haematology\, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023\, she returned home and started as BMT Consultant at the The Nairobi West Hospital. She is currently based at the Aga Khan University Hospital. \nHer BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol\, GVHD prophylaxis and post-transplant management of immune suppression\, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia\, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials. \nDr Grace Mbatia\nGrace Mbatia is currently serving as Full-time faculty at the Aga Khan University\, Nairobi providing clinical care to children with blood and cancer disorders as well as supporting paediatric post-graduate medical training for future paediatricians. Her core clinical interests lie in providing care to children with brain and solid tumors whereas her broader interests include supporting medical education\, health-systems research and the optimization of both general paediatric and paediatric blood and cancer care in resource-constrained settings. \nDr Catherine Muendo\nCatherine Muendo is a Paediatric Hematologist and Oncologist who completed her fellowship training at Makerere university in collaboration with Mulago National Referral Hospital\, Baylor college of medicine and Texas cancer children’s hospital. \nShe works as a consultant paediatrician at Kenyatta National Hospital. Dr Muendo received her medical degree (MBChB) and pediatrics and child health degree (MMed) at the University of Nairobi. \nShe is enthusiastic about improving the outcomes of children with blood and cancer disorders in Kenya through novel interventions that are sustainable in a resource limited setting. \nDr Irene Nzamu (Moderator)\nIrene Nzamu is a Pediatric Hematologist Oncologist. She is the Head of the Pediatric Hemato Oncology Unit at the Kenyatta National Hospital. \nDr Nzamu attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi. She did her Fellowship in Pediatric Hematology & Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital. \nShe is passionate about offering evidence based\, affordable care for children with cancer & blood diseases in our resource limited settings.[/vc_column_text][vc_video link=”” title=”Webinar Recording”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/sickle-cell-disease/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/sickle-cell.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240725T190000
DTEND;TZID=Africa/Nairobi:20240725T203000
DTSTAMP:20260424T035851
CREATED:20240829T083615Z
LAST-MODIFIED:20250622T144125Z
UID:9940-1721934000-1721939400@kesho-kenya.org
SUMMARY:Management of Esophageal Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Primus Ocieng\nPrimus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital. \nHe has keen interest in Head and neck\, prostate cancer treatment. Dr. Ochieng is committed to ensure the program produce well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this\, he is keen in collaborating with various centers in the developed world in areas of training\, research and skill development. \nDr Omondi Ogude\nOmondi Ogude is a medical oncologist serving as a director of the Sandton Oncology Medical Group and practices at the Sandton Oncology Centre. Dr. Ogude received his medical degree in 2005 from the University of the Witwatersrand. He subsequently completed his Internal Medicine specialisation in 2011 and a medical oncology fellowship in 2014 at the same institution. \nDr. Ogude specialises in Lung\, Breast\, Gastrointestinal\, and Gynecological malignancies and is actively involved in research. He serves as a principal investigator and sub-investigator on multiple trials. He also chairs and sits on various multidisciplinary forums in Johannesburg and advisory boards locally and internationally. \nHe is dedicated to advocacy work in oncology\, serving as a director and board member of Campaigning For Cancer and The Johnson Rose Cancer Foundation\, both non-profit organisations that promote better cancer care and awareness in South Africa. \nHe is an active member of the South African Oncology Consortium\, European Society of Medical Oncology\, and American Society of Clinical Oncology. \nDr Cathy Samo \nCathy Samo is a general pathologist at Coast General Teaching & Referral Hospital. Her main areas of interest include anatomic pathology\, hematopathology and forensic pathology. \nDr Noordin Bashir (Moderator)\nNoordin Bashir Somo is a consultant Clinical Oncologist working at Defense Forces Memorial Hospital\, Nairobi.He  has a Master’s degree in Clinical Oncology and Nuclear Medicine from Alexandria University\, Egypt. \nHe is a member of Kenya Society of Hematology and Oncology (KESHO)\, American Society of Clinical Oncologist (ASCO) and the European Society of Medical Oncologists (ESMO). \nHis areas of interest include breast cancer\, lung cancer\, gastrointestinal cancers\, CNS\, gynecological and genitourinary cancers.[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/management-of-esophageal-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/08/Management-of-Esophageal-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240719T190000
DTEND;TZID=Africa/Nairobi:20240719T203000
DTSTAMP:20260424T035851
CREATED:20240704T133810Z
LAST-MODIFIED:20250622T144125Z
UID:9886-1721415600-1721421000@kesho-kenya.org
SUMMARY:Meet the Expert Dinner
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nEXPERT PROFILES:\nProfessor David Carbone\nDavid Carbone is Professor of Internal Medicine\, Director of the James Thoracic Oncology Center at the OSUMC and holds the Barbara J. Bonner Chair in Lung Research. He graduated summa cum laude from Amherst College in 1977 and received an MD and PhD in Molecular Biology and Genetics at Johns Hopkins University in 1985. He then did an Internal Medicine internship and residency at Johns Hopkins Hospital through 1988 followed by a Medical Oncology fellowship \nat the National Cancer Institute in Bethesda\, MD. At Vanderbilt he was Professor of Medicine\, Cell Biology\, and Cancer Biology\, and Director of the Thoracic/Head and Neck Cancer Program\, Director and Principal Investigator of the Vanderbilt Specialized Program of Research Excellence (SPORE) in Lung Cancer for 11 years and PI of the Strategic Partnering to Evaluate Cancer Signatures (SPECS) in Lung Cancer UO1 consortium. He was recruited to The Ohio State University in 2012 to direct the James Thoracic Oncology Center. \nHis research interests\, grant support and publications have been focused on lung cancer\, and specifically lung cancer genetics\, cancer immunotherapy\, tumor-associated immunosuppression mechanisms. He has over 300+ peer-reviewed publications\, books and review articles\, has served on several NCI grant review panels\, including the clinical program project parent committee\, \nand has continuous NCI funding since early in his career. He has served on the Board of Scientific Counselors for the NCI and as Chair of the Lung Biology subcommittee for the Eastern Cooperative Oncology Group. His a Past President of the International Association for the Study of Lung Cancer (IASLC) and currently co-chair of the NCI/CTEP Thoracic Malignancy Steering Committee. \nDr Manel Haj Mansour\nManel Haj is a Consultant Medical Oncologist and Section Head of Medical Oncology at Aga Khan University Hospital\, Nairobi. She is also the current Fellowship Program Director in The Department of Hematology Oncology. \nShe graduated from the University Tunis\, and undertook her Core Internal Medicine and Medical Oncology training the most prestigious University Hospitals in Tunisia where she received her certificate of completion in 2017. She has also received part of training at the Gustave Roussy Institute of cancer treatment in Paris\, France. \nShe has previously worked as consultant medical oncologist and lecturer at Abdurrahman Mami University Hospital\, Tunisia and at a leading health care facility in Nairobi.\nDr Haj is passionate about increasing cancer awareness and promoting screening and early detection. She has also a special interest in precision oncology and clinical research and is currently investigator in several clinical trials in the Cancer Research Unit at Aga Khan University Hospital. \nShe is a member of American (ASCO)\, European (ESMO) \,Tunisian and Kenyan societies of medical oncology ((STOM  and KESHO). \nDr Allan Njau\nAllan Njau is an Assistant Professor in the department of Pathology and Laboratory Medicine at the Aga Khan University Hospital. He holds a bachelor’s degree in medicine and surgery from the University of Nairobi (2008)\, Master of medicine in Anatomic Pathology from the Aga Khan University (2016) and a fellowship in Molecular Pathology from Augusta University\, GA\, USA (2020). His interests are in the fields of precision medicine\, molecular assays especially for oncology and has a vibrant research agenda in the areas of lung cancer\, pathology informatics\, endometrial carcinoma\, extrapulmonary tuberculosis\, Covid-19\, gastric cancer and Helicobacter pylori infections. \nDr Njau is dynamic at adopting and developing molecular testing programs and is a proponent of building local capacity for precision medicine oncology. He is a member of the Association for Molecular Pathology and American Association of Cancer Research. \nWebinar Recording\n[vc_video link=”https://vimeo.com/988401622 “][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/meet-the-expert-dinner/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2024/07/Lung-Cancer-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240718T190000
DTEND;TZID=Africa/Nairobi:20240718T203000
DTSTAMP:20260424T035851
CREATED:20240704T120114Z
LAST-MODIFIED:20240731T182937Z
UID:9859-1721329200-1721334600@kesho-kenya.org
SUMMARY:Osteogenic Sarcoma
DESCRIPTION:[vc_row][vc_column][vc_column_text] \n\n\n\n\n\n\n\n\nSPEAKER PROFILES:\nDr Angela McLigeyo\nAngela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi\, a M.Sc. in Clinical Oncology from Ulm University (Germany)\, and a Fellowship in Medical Oncology from the University of Nairobi. In addition\, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO)\, European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East\, Central and Southern Africa College of Physicians. \nHer core skills are in clinical decision making in internal medicine and oncology\, conducting trainings\, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols. \nDr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities\, conducts research in oncology and internal medicine when opportunities arise\, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences. \nProfessor Parmenas Oroko\nParmenas Kibagendi Oroko is a distinguished orthopaedic surgeon and Clinical Associate Professor at Aga Khan University Hospital Nairobi. He is also the current chairman of the Kenya Orthopaedic Association. He holds an impressive array of qualifications including MBChB\, M.Med (Surgery)\, FRCS (Ed)\, FRCSEd (Tr & Orth)\, and FRCS Eng (Tr & Orth). Specializing in lower limb arthroplasty\, pelvic and acetabular reconstruction\, as well as knee and shoulder arthroscopic surgery\, Prof. Oroko has established himself as a leading expert in his field. \nProf Oroko’s professional journey began in 1986 as a tutorial fellow at the University of Nairobi. His dedication to orthopaedics took him to the UK where he trained and worked as a consultant orthopaedic surgeon\, specializing in lower limb arthroplasty. Upon returning to Kenya in 2011\, he continued his practice and introduced advanced surgical techniques at Aga Khan University Hospital. \nHe is heavily involved in training and mentoring residents\, aiming to improve orthopaedic practice in the region. Prof Oroko’s academic contributions include extensive teaching at the University of Nairobi and Aga Khan University\, supervision of dissertation research\, and numerous publications in peer-reviewed journals. \nAdditionally\, Prof Oroko has played significant roles in administrative capacities\, including leading the expansion of orthopaedic services and contributing to reorganization efforts within the Lanarkshire Health Board in the UK. His research focuses on orthopaedic trauma and arthroplasty\, with his work presented at various local and international conferences. \nProf Oroko’s vision is to develop a center of excellence in orthopaedics in East Africa\, providing top-quality services and training future specialists in the region. \nDr Rogers Mongare (Moderator)\nRogers Mongare is a Clinical and Radiation Oncologist at the Cancer Treatment Centre\, Kenyatta National Hospital (KNH) with special interest in Head & Neck\, GIT\, Sarcomas\, Urological\, Breast and Gynaecological malignancies. He conducts clinical practice and clinical teaching at the largest referral hospital in the region. \nHe is an honorary lecturer in Radiation Oncology at the Department of Diagnostic Imaging and Radiation Medicine\, University of Nairobi. He is an active participant at the KNH multidisciplinary tumour boards working closely with other specialists in patient care. He is keen on research\, evidence based medicine and passionate on ways of improving treatment outcomes in patients using systemic and radiation treatments. He is an astute specialist oncologist who enjoys the technicalities of planning treatment\, using advanced and conventional radiation techniques with computers to deliver treatment. He participates in the technical working groups responsible for developing institutional and national radiotherapy protocols. Besides\, he never misses his weekend cross country runs. \nWebinar Recording\n[vc_video link=”https://vimeo.com/986680651″]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/osteogenic-sarcoma/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/Osteogenic-Sarcoma.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240711T190000
DTEND;TZID=Africa/Nairobi:20240711T203000
DTSTAMP:20260424T035851
CREATED:20240606T084036Z
LAST-MODIFIED:20240731T182527Z
UID:9792-1720724400-1720729800@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nWebinar Recording\n[vc_video link=”https://vimeo.com/982788827″][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/prostate-cancer-3/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240622T070000
DTEND;TZID=Africa/Nairobi:20240622T203000
DTSTAMP:20260424T035851
CREATED:20240606T083949Z
LAST-MODIFIED:20240731T191227Z
UID:9790-1719039600-1719088200@kesho-kenya.org
SUMMARY:EA Oncology Summit
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nWebinar Recording\n[vc_video link=”https://vimeo.com/970162437″][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/ea-oncology-summit/
CATEGORIES:CME 2024,Conferences,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240613T190000
DTEND;TZID=Africa/Nairobi:20240613T203000
DTSTAMP:20260424T035851
CREATED:20240606T083849Z
LAST-MODIFIED:20240731T181046Z
UID:9788-1718305200-1718310600@kesho-kenya.org
SUMMARY:Head and Neck Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES:[/vc_column_text][vc_column_text]Dr Njoki Njiraini\nNjoki Njiraini is a Consultant Clinical Oncologist based at the Kenyatta National Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a Bachelor’s Degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme. \nDr Muhammad Suhail Anwar \nMuhammad Suhail Anwar is a Consultant Medical Oncologist at the King Faisal Specialist Hospital & Research Centre and Adjunct Assistant Professor in Medical Oncology at Al Faisal University in Riyadh\, Saudi Arabia. He holds several prestigious qualifications\, including FRCR and MRCP from renowned institutions in the UK and Ireland. Dr. Anwar has been actively involved in the medical field since obtaining his MBBS degree in 1989. \nThroughout his career\, Dr. Anwar has been dedicated to research and education\, mentoring fellows\, residents\, and medical students. He has authored numerous publications and presented his work at various national and international conferences. Dr. Anwar’s research interests include breast and gynecological cancers\, and he has been involved in several clinical trials.\nHe is a member of the several professional bodies:\n•              Classification and Registration with Saudi Health Council (SCFHS)\n•              Member of the Royal College of Physicians (UK)\n•              Fellow of the Royal College of Radiologists (UK)\n•              Member of the Royal College of Physicians (IRELAND)\n•              Former Member British Gynaecological Cancer Society (UK) \nDr Primus Ochieng (Moderator)\nPrimus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital. \nHe has keen interest in Head and neck\, prostate cancer treatment. Dr. Ochieng is committed to ensure the program produce well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this\, he is keen in collaborating with various centers in the developed world in areas of training\, research and skill development. \nWebinar Recording\n[vc_video link=”https://vimeo.com/957950625 “][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/head-and-neck-cancer-4/
CATEGORIES:CME 2024,Conferences,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/06/Head-and-Neck-Cancer.jpg
END:VEVENT
END:VCALENDAR